marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
OncoCyte Corporation Financial Statements 2011-2024 | OCX
Annual Financial Statements OncoCyte Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
38.8 K | 130 K | 263 M | 137 M | 197 M | 122 M | 155 M | 87.2 M | - | - | - | - |
Shares |
111 K | 88.9 K | 51.3 M | 51.3 M | 37.8 M | 30.2 M | 26.5 M | 21 M | - | - | - | - |
Historical Prices |
0.35 | 1.46 | 4.92 | 2.15 | 3.32 | 3.3 | 5.65 | 3.84 | - | - | - | - |
Net Income |
-72.9 M | -64.1 M | -29.9 M | -22.4 M | -15.8 M | -19.4 M | -11.2 M | -8.74 M | -4.99 M | -3.5 M | - | - |
Revenue |
958 K | 2.2 M | 1.22 M | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
880 K | 697 K | 1.86 M | - | - | - | - | - | - | - | - | - |
Gross Profit |
-18 K | 1.42 M | -639 K | - | - | - | - | - | - | - | - | - |
Operating Income |
-18 M | -53.7 M | -29.7 M | -22.2 M | -15.2 M | -18.8 M | -11.1 M | -8.72 M | -4.97 M | - | - | - |
Interest Expense |
-67 K | -37 K | 27 K | -3 K | 91 K | -309 K | - | 18 K | - | - | - | - |
EBITDA |
-16.5 M | -52.9 M | -31.8 M | -21.9 M | -14.6 M | -18.3 M | -10.8 M | -8.44 M | -4.69 M | -3.22 M | - | - |
Operating Expenses |
18 M | 55.1 M | 33.1 M | 22 M | 15 M | 19 M | 11 M | 9 M | 5 M | 3 M | - | - |
General and Administrative Expenses |
21.9 M | 22.3 M | 16.8 M | 13.3 M | 7.01 M | 9.23 M | 5.46 M | 4.19 M | 1.01 M | 552 K | - | - |
All numbers in USD currency
Quarterly Income Statement OncoCyte Corporation
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
13.7 M | 12.9 M | 8.26 M | 8.26 M | 8.26 M | 8.09 M | 5.96 M | 5.93 M | 5.93 K | 5.65 K | 92.2 M | 92.2 M | 91.5 M | 89.8 M | 82.1 M | 69.1 M | 67.2 M | 65.8 M | 61.5 M | 57 M | 52 K | 52 K | 46.6 K | 40.7 M | 40.2 M | 38.7 M | 31.7 M | 31.5 M | 30.9 K | 29.4 M | 29 M | 28.7 M | 26.6 M | 25.4 M | 25.4 M | 25.4 M | 21 M | 21.2 M | 18.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-13.5 M | -4.53 M | -9.13 M | - | -6.49 M | -8.33 M | 3.03 M | - | -9.33 M | -8.3 M | -10.3 M | -35.9 M | -13.8 M | -10.5 M | -3.92 M | -6.31 M | -6.78 M | -9.11 M | -7.73 M | - | -5.22 M | -5.38 M | -3.86 M | - | -2.97 M | -4.5 M | -3.78 M | - | -6.91 M | -3.8 M | -4.7 M | - | -2.6 M | -2.54 M | -2.93 M | - | -2.42 M | -1.41 M | -1.37 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
115 K | 104 K | 176 K | - | 429 K | 463 K | 297 K | - | 67 K | 237 K | 1.42 M | 3.59 M | 984 K | 2.03 M | 1.12 M | 503 K | 555 K | 143 K | 16 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
43 K | 32 K | 252 K | - | 159 K | 169 K | 265 K | - | 314 K | 183 K | 1.02 M | 2.22 M | 860 K | 1.35 M | 738 K | 716 K | 601 K | 365 K | 173 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
50 K | 50 K | -98 K | - | 248 K | 272 K | 10 K | - | -269 K | 31 K | -533 K | - | -866 K | -394 K | 79 K | - | -46 K | -222 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-13.5 M | -4.63 M | -9.27 M | - | -6.51 M | -8.29 M | 5.85 M | - | -1.71 M | -1.63 M | -9.9 M | -35.7 M | -13.6 M | -13.6 M | -11.4 M | -6.27 M | -6.24 M | -8.77 M | -8.43 M | - | -5.26 M | -5.46 M | -4 M | - | -3.02 M | -4.23 M | -3.91 M | - | -6.84 M | -3.59 M | -4.53 M | - | -2.58 M | -2.53 M | -2.93 M | - | -2.41 M | -1.4 M | -1.37 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
53 K | 110 K | 153 K | - | 127 K | -1 K | -1 K | - | 62 K | 278 K | -36 K | - | -8 K | 16 K | 2 K | - | 1 K | 20 K | 8 K | - | -25 K | -25 K | -26 K | - | -4 K | -2 K | -2 K | - | -71 K | -65 K | -159 K | - | -13 K | -11 K | - | - | -1 K | -6 K | -2 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-13.2 M | -4.33 M | -8.95 M | - | -6.11 M | -7.86 M | 6.3 M | - | -1.32 M | -1.24 M | -9.61 M | -35.7 M | -13.3 M | -13.4 M | -11.1 M | -6.27 M | -6.18 M | -8.7 M | -8.37 M | - | -5.17 M | -5.38 M | -3.89 M | - | -2.91 M | -4.12 M | -3.8 M | - | -6.74 M | -3.51 M | -4.46 M | - | -2.53 M | -2.48 M | -2.92 M | - | -2.37 M | -1.38 M | -1.36 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
13.6 M | 4.68 M | 9.17 M | - | 6.76 M | 8.57 M | -5.84 M | - | 1.44 M | 1.66 M | 9.36 M | - | 12.7 M | 13.2 M | 11.4 M | - | 6.2 M | 8.55 M | 8.45 M | - | 5.26 M | 5.46 M | 4 M | - | 3.02 M | 4.23 M | 3.91 M | - | 6.84 M | 3.59 M | 4.53 M | - | 2.58 M | 2.53 M | 2.93 M | - | 2.41 M | 1.4 M | 1.37 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
2.56 M | 2.41 M | 2.67 M | - | 2.49 M | 3.53 M | 3.41 M | - | 5.7 M | 5.44 M | 5.65 M | 4.14 M | 5.5 M | 7.93 M | 4.76 M | 3.41 M | 5 M | 3.76 M | 4.62 M | - | 3 M | 3.64 M | 2.45 M | - | 1.31 M | 1.34 M | 1.79 M | - | 4.29 M | 1.12 M | 2.04 M | - | 1.06 M | 1.07 M | 1.02 M | - | 1.31 M | 519 K | 250 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency